BUNKA CHRISTOPHER bought LEXX
July 30, 2025 · Form 4 insider transaction
BUNKA CHRISTOPHER bought 11,900 shares of Lexaria Bioscience Corp. at $0.91 per share, a transaction worth $10.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,900
Price
$0.91
Total value
$10.9K
InsiderBUNKA CHRISTOPHER
Role—
Securitycommon shares
Transaction codeP: Open-market purchase
Transaction dateJuly 30, 2025
Filing dateJuly 30, 2025
Shares owned after281,912
OwnershipIndirect
10b5-1 planNo
AmendedNo